logo
Share SHARE
FONT-SIZE Plus   Neg

Bluefly Slips To Q4 Loss

Bluefly, Inc. (BFLY) reported a net loss of $6.2 million or $0.22 per share, compared to net income of $0.3 million or $0.01 per share for the year-ago quarter.

Net sales increased 3% to $29.4 million from $28.6 million a year earlier.

Gross profit margin for the fourth quarter was 21.9% compared to 34.9% in the fourth quarter of 2010. Total operating expenses for the quarter increased 30% to $12.6 million from $9.6 million last year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Coca-Cola Company (KO) reported a profit for the first-quarter of 2017 that declined 20 percent from the prior year. Net revenues declined 11%, reflecting unfavorable impacts from structural changes of 10% and foreign currency of 1%. The company remains on track to deliver its underlying revenue and profit targets for the full year. Eli Lilly and Co. (LLY) reported a loss for the first quarter of 2017 compared to profit in the prior year, primarily hurt by lower operating income, partially offset by higher other income. But, quarterly revenue increased 7 percent, driven by 9 percent pharmaceutical volume growth from Trulicity, Taltz and other new products. Capricor Therapeutics, Inc., a clinical-stage biotechnology company for cardiac and other medical conditions, announced Tuesday positive six-month results from the randomized phase I/II HOPE clinical trial in Duchenne muscular dystrophy or DMD. The HOPE clinical trial was designed to evaluate the safety and exploratory efficacy of CAP-1002.
comments powered by Disqus
Follow RTT